Published on 24/12/2025
How to Ensure Attributable Data in Electronic Health Records (EHR) for Clinical Trials
What Does “Attributable” Mean in Clinical Data Integrity?
In the realm of GxP-compliant data, the first letter of ALCOA—Attributable—is foundational. It requires that every piece of clinical data be linked to the person who created or modified it. Whether paper-based or electronic, the identity of the data originator must be unmistakably documented. In the context of Electronic Health Records (EHR), this principle becomes critical due to the high reliance on digital records across sites and sponsors.
The FDA’s Guidance on Electronic Source Data in Clinical Investigations emphasizes that attribution must be evident in EHR systems through electronic signatures, unique logins, and time-stamped audit trails. Similarly, ICH E6(R2) mandates that systems used for data capture must enable traceability of the user performing the task.
Example: If a nurse records a subject’s blood pressure in the EHR at 08:30 AM, the system must log the
Designing EHR Systems to Meet Attributable Standards
Ensuring Attributable data in an EHR system starts with a robust system design. The following features are critical:
- Unique user IDs: Each individual must have their own secure login credentials. Shared logins violate attribution rules.
- Time-stamped audit trails: Systems must maintain logs of every activity, including who did what and when.
- Role-based access controls: Only authorized users should be allowed to perform specific actions, such as modifying patient records or signing off on visits.
- Electronic signatures: These should be legally binding and traceable to the specific user.
A dummy case example:
| Record | User ID | Timestamp | Role | Action |
|---|---|---|---|---|
| Subject 105 – Visit 2 | nurse_amy_01 | 2025-06-10 08:32 | Study Nurse | Entered vital signs |
| Subject 105 – Visit 2 | cra_ravi_04 | 2025-06-10 15:10 | CRA | Source data verified |
Real-World Regulatory Examples and Common EHR Issues
A 2021 FDA inspection of a Phase II oncology trial uncovered non-compliance where multiple site staff were using a shared EHR login. As a result, it was impossible to determine who had recorded or modified critical data entries, including SAE documentation. This led to a 483 observation citing failure to ensure Attributable data in compliance with 21 CFR Part 11.
Similarly, the EMA released a Q&A document in 2022 highlighting how the lack of proper audit trail visibility in EHRs can compromise data integrity. It advised sponsors and sites to implement access logs and automated tracking tools.
To mitigate these issues, companies must:
- Validate EHR systems to confirm they retain audit trails and support user attribution.
- Train staff on the importance of using personal credentials.
- Perform periodic access audits to detect anomalies or shared logins.
You can find detailed guidance on EHR validation at pharmaValidation.in and inspection trends on PharmaRegulatory.in.
Audit Trails and Their Role in Attributable Compliance
An audit trail is the backbone of attribution in any electronic system. It records who performed an action, what was changed, when it was changed, and why (if applicable). Without audit trails, data entries in EHRs are unverifiable and untrustworthy during audits or inspections.
Regulatory expectations require that:
- Audit trails be permanent and tamper-evident.
- Every data point modification is traceable back to the user.
- Justifications for edits or deletions are captured within the system.
For example, if a lab technician updates a glucose level from 130 mg/dL to 103 mg/dL, the system must preserve the original value, identify the technician, time of change, and rationale. Failing to do so can be a critical data integrity issue.
Here’s a simplified dummy audit trail for demonstration:
| Data Field | Old Value | New Value | User ID | Date/Time | Reason |
|---|---|---|---|---|---|
| Glucose Level | 130 | 103 | labtech_john | 2025-07-12 10:12 | Transcription error correction |
Strategies to Improve Attribution in Clinical Site Operations
Improving attribution isn’t just an IT function—it also depends heavily on site behavior and governance. Consider the following operational strategies:
- Access Policies: Establish SOPs that prohibit shared logins and define the process for requesting credentials.
- User Deactivation: Ensure that users who leave the study have their access removed immediately to prevent unauthorized changes.
- eSignature Training: Educate staff on proper use of electronic signatures and how they legally bind data entries.
- Monitoring and Audits: Include attribution checks in routine monitoring visits and internal audits.
A real-world example shared by PharmaSOP.in discussed a sponsor’s CAPA following an audit finding where two coordinators at a cardiology site had continued using a departed PI’s login. The sponsor implemented biometric login systems and enforced biometric and password policies, significantly reducing similar risks in future trials.
Conclusion: Attribution as a Pillar of Trust in Clinical Research
In clinical trials, the integrity and reliability of every data point are only as strong as their traceability. Ensuring Attributable data in EHR systems supports not only regulatory compliance but also builds sponsor and patient trust in the outcome of the study.
As the industry moves toward decentralized and remote trials, the emphasis on robust electronic systems that preserve identity, timing, and accountability becomes even more critical. Sponsors and sites must invest in validated EHRs, enforce attribution policies, and stay current with GxP expectations to maintain audit readiness.
For deeper insight into system validation and compliance approaches, visit WHO publications on GCP and explore implementation models on ClinicalStudies.in.